188 related articles for article (PubMed ID: 25894959)
1. Risk-based individualisation of target haemoglobin in haemodialysis patients with renal anaemia in the post-TREAT era: theoretical attitudes versus actual practice patterns (MONITOR-CKD5 study).
Gesualdo L; Combe C; Covic A; Dellanna F; Goldsmith D; London G; Mann JF; Zaoui P; Turner M; Muenzberg M; MacDonald K; Abraham I
Int Urol Nephrol; 2015 May; 47(5):837-45. PubMed ID: 25894959
[TBL] [Abstract][Full Text] [Related]
2. Effects of proactive iron and erythropoiesis-stimulating agent protocol implementation on achieving clinical guideline targets for anaemia in a satellite haemodialysis patient cohort.
Yong K; Kairaitis L
Nephrology (Carlton); 2010 Apr; 15(3):288-93. PubMed ID: 20470296
[TBL] [Abstract][Full Text] [Related]
3. UK Renal Registry 16th annual report: chapter 10 haemoglobin, ferritin and erythropoietin amongst UK adult dialysis patients in 2012: national and centre-specific analyses.
Rao A; Gilg J; Williams A
Nephron Clin Pract; 2013; 125(1-4):183-208. PubMed ID: 24662174
[TBL] [Abstract][Full Text] [Related]
4. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and predictors of the sub-target Hb level in children on dialysis.
van Stralen KJ; Krischock L; Schaefer F; Verrina E; Groothoff JW; Evans J; Heaf J; Ivanov D; Kostic M; Maringhini S; Podracká L; Printza N; Pundziene B; Reusz GS; Vondrak K; Jager KJ; Tizard EJ;
Nephrol Dial Transplant; 2012 Oct; 27(10):3950-7. PubMed ID: 22740719
[TBL] [Abstract][Full Text] [Related]
6. The Impact of Lowering Haemoglobin Targets on Patterns of Erythropoiesis-Stimulating Agent Use in Patients on Haemodialysis.
Hazara AM; Owen SJ; Bhandari S
Blood Purif; 2016; 41(4):287-92. PubMed ID: 26820617
[TBL] [Abstract][Full Text] [Related]
7. Chapter 8 Haemoglobin, ferritin and erythropoietin amongst UK adult dialysis patients in 2010: national and centre-specific analyses.
Webb L; Gilg J; Wilkie M
Nephron Clin Pract; 2012; 120 Suppl 1():c145-74. PubMed ID: 22964566
[TBL] [Abstract][Full Text] [Related]
8. A pharmacoepidemiological study of the multi-level determinants, predictors, and clinical outcomes of biosimilar epoetin alfa for renal anaemia in haemodialysis patients: background and methodology of the MONITOR-CKD5 study.
Gesualdo L; London G; Turner M; Lee C; Macdonald K; Goldsmith D; Covic A; Zaoui P; Combe C; Mann J; Dellanna F; Muenzberg M; Abraham I
Intern Emerg Med; 2013 Aug; 8(5):389-99. PubMed ID: 21590439
[TBL] [Abstract][Full Text] [Related]
9. ORAMA: a study to investigate EBPG impact on renal anaemia - design and baseline data.
Locatelli F; Covic A; Macdougall IC; Wiecek A;
J Nephrol; 2008; 21(4):592-603. PubMed ID: 18651551
[TBL] [Abstract][Full Text] [Related]
10. Erythropoiesis-stimulating agent dosing, haemoglobin and ferritin levels in UK haemodialysis patients 2005-13.
Birnie K; Caskey F; Ben-Shlomo Y; Sterne JA; Gilg J; Nitsch D; Tomson C
Nephrol Dial Transplant; 2017 Apr; 32(4):692-698. PubMed ID: 27190350
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the therapeutic effects of epoetin zeta to epoetin alfa in the maintenance phase of renal anaemia treatment.
Wizemann V; Rutkowski B; Baldamus C; Scigalla P; Koytchev R;
Curr Med Res Opin; 2008 Mar; 24(3):625-37. PubMed ID: 18208642
[TBL] [Abstract][Full Text] [Related]
12. Optimal treatment of renal anaemia (OPTA): improving the efficacy and efficiency of renal anaemia therapy in haemodialysis patients receiving intravenous epoetin.
Hörl WH; Vanrenterghem Y; Canaud B; Mann J; Teatini U; Wanner C; Wikström B
Nephrol Dial Transplant; 2005 May; 20 Suppl 3():iii25-32. PubMed ID: 15824127
[TBL] [Abstract][Full Text] [Related]
13. Results of the European Survey on Anaemia Management 2003 (ESAM 2003): current status of anaemia management in dialysis patients, factors affecting epoetin dosage and changes in anaemia management over the last 5 years.
Jacobs C; Frei D; Perkins AC
Nephrol Dial Transplant; 2005 May; 20 Suppl 3():iii3-24. PubMed ID: 15824128
[TBL] [Abstract][Full Text] [Related]
14. A prospective multicentre study of the role of anaemia as a risk factor in haemodialysis patients: the MAR Study.
Portolés J; López-Gómez JM; Aljama P
Nephrol Dial Transplant; 2007 Feb; 22(2):500-7. PubMed ID: 17023492
[TBL] [Abstract][Full Text] [Related]
15. Developing a classification system for haemoglobin management in patients with end-stage renal disease on haemodialysis: a secondary data analysis.
Kesztyüs T; Simonsmeier U; Kesztyüs D
BMJ Open; 2017 Nov; 7(11):e017423. PubMed ID: 29122793
[TBL] [Abstract][Full Text] [Related]
16. Randomized trial on the therapeutic equivalence between Eprex and GerEPO in patients on haemodialysis.
Goh BL; Ong LM; Sivanandam S; Lim TO; Morad Z;
Nephrology (Carlton); 2007 Oct; 12(5):431-6. PubMed ID: 17803464
[TBL] [Abstract][Full Text] [Related]
17. Comparative efficacy of a team-led treatment protocol for the management of renal anaemia.
Kotwal SS; Lan P; MacLeod A; Jardine M; Snelling P; Craig J; Cass A; Gallagher M
Nephrology (Carlton); 2013 Oct; 18(10):649-54. PubMed ID: 23889845
[TBL] [Abstract][Full Text] [Related]
18. Maintaining control over haemoglobin levels: optimizing the management of anaemia in chronic kidney disease.
Bárány P; Müller HJ
Nephrol Dial Transplant; 2007 Jun; 22 Suppl 4():iv10-iv18. PubMed ID: 17526545
[TBL] [Abstract][Full Text] [Related]
19. Anaemia management in non-dialysis chronic kidney disease: flexibility of target to target stability?
De Nicola L; Minutolo R; Conte G
Nephron Clin Pract; 2010; 114(4):c236-41. PubMed ID: 20090364
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of C.E.R.A. in Routine Clinical Practice for Correction of Anaemia and Maintenance of the Haemoglobin Levels in CKD Patients not on Dialysis.
Promod PJ; Deshpande R; Mohanty NK; Kulkarni S; Shah HA; Ganju A; Kukreja A; Joshi S
J Assoc Physicians India; 2017 Mar; 65(3):52-57. PubMed ID: 28462544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
